Tremfya 200 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQS8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,292
Award facts
- Contract value 100% obligated
- $15,291.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,291.86 by the Defense Logistics Agency on December 23, 2025, with a completion date of January 15, 2026. The award is for TREMFYA 200 mg/2 mL pen injections (2 mL quantity), a specialty pharmaceutical product used in the treatment of psoriasis and other dermatological conditions. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract represents a child order under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
The Defense Logistics Agency Medical Supply Chain relies on AmerisourceBergen Drug Corp as a critical vendor for supplying an extensive portfolio of pharmaceutical products and medical supplies to support Department of Defense healthcare operations and military beneficiaries worldwide. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse medical procurement requirements, ranging from small-value transactions to substantial orders, with particular strength in specialty medications, brand-name and generic pharmaceuticals, and specialized medical devices. This delivery order reflects the ongoing operational demand within the military healthcare system for specialty dermatological treatments to support active-duty personnel, retirees, and their families.
Quick answers
Who was awarded contract SPE2DR26FQS8M?
SPE2DR26FQS8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FQS8M worth?
The government has obligated $15,292 on SPE2DR26FQS8M.
Is contract SPE2DR26FQS8M an order under another contract?
Yes. SPE2DR26FQS8M is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS8M competed?
The extent of competition for SPE2DR26FQS8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award